InsidersTradesSigma
Elicera Therapeutics AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the Elicera Therapeutics AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Elicera Therapeutics AB has recorded 3 insider filings. Market capitalisation: €151.2m. The latest transaction was filed on 12 March 2025 (Purchase). Among the most active insiders: Margareth Jorvid. Every trade is openly available.
3
Insider Decl.
0
Thresholds
€11,763
3 ops.
Buy Volume
·
0 ops.
Sell Volume
28Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 March 2025
Declarations3 total
21,700 shares@ €0.16850.0024% mcap100.0% of flowInterimsaktieFI:A003M484-1
Ideal exit: 6 Dec 2025 (T+270)
43,211 shares@ €0.16850.0048% mcap100.0% of flowInterimsaktieFI:A003M442-1
Ideal exit: 6 Dec 2025 (T+270)
18,000 shares@ €0.04570.0005% mcap100.0% of flowOptionFI:A003M381-1
Ideal exit: 5 Dec 2025 (T+270)
3 of 3 declarations